PUBLISHER: IMARC | PRODUCT CODE: 1236760
PUBLISHER: IMARC | PRODUCT CODE: 1236760
The North America cold chain market size reached US$ 67.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 104.1 Billion by 2028, exhibiting a growth rate (CAGR) of 7.3% during 2023-2028.
Cold chain is a temperature-controlled supply chain, it involves a series of refrigerated storage, production and distribution activities, along with equipments that ensure that a desired temperature range is maintained. Cold chains preserve, extend and ensure the shelf life of various temperature sensitive products.
The market for cold chain services is currently exhibiting strong growth in North America. A key factor driving the demand of the cold chain market in North America has been a change in the dietary habits in the region. As a result of rising obesity levels and an increasing prevalence of lifestyle diseases, consumers are increasing their intake of proteins, vitamins, minerals, good fats, etc. and reducing their carbohydrate intake. This has catalyzed the demand of food products such as meat, fruits, vegetables and dairy products in the region. These products are temperature sensitive and require cold chains to be stored and transported from one place to another. Moreover, the United States represents the worlds largest market for temperature sensitive healthcare products such as biopharmaceuticals, vaccines and clinical trial materials. The potency of biopharmaceuticals and vaccines requires temperature-controlled packaging, storage and transportation. Any sudden temperature variation may result in the loss of chemical activity and make the drug harmful for the human body. Moreover, the rising number of clinical trials employing various temperature sensitive materials such as blood samples, tissue samples and certain drugs, have also catalyzed the market growth.